BIRMINGHAM, Alabama--BioHorizons Implant Systems, Inc. has introduced a new line of tapered internal implants that feature a unique thread design and proven surface engineering technology.
This product introduction is the first from BioHorizons to address the tapered market segment that accounts for more than 50 percent of the U.S. dental implant market.
The tapered internal implants incorporate the Laser-Lok precision laser collar surface treatment, which controls cellular growth and directs hard and soft tissue attachment onto dental implants.
The result of more than 15 years of evidence-based research and documented clinical trials, the patented 8 and 12 micron Laser-Lok channels play a vital role in inhibiting epithelial downgrowth and attaching and retaining crestal bone.
The implant design and surface treatment displayed improved hard and soft tissue response leading to excellent esthetic results in animal and human clinical trials.
"These new implants will offer supreme esthetic and clinical results to our global dental implant customers," commented Steve Boggan, president and CEO of BioHorizons. "Building on BioHorizons' commitment to science, innovation and service, we are pleased to bring such a novel product to the dental implant industry."
